167 related articles for article (PubMed ID: 21343461)
1. Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
Lai CC; Liu WL; Ko WC; Chen YH; Tan HR; Huang YT; Hsueh PR
Antimicrob Agents Chemother; 2011 May; 55(5):2084-91. PubMed ID: 21343461
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.
Lai CC; Tan CK; Lin SH; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
J Antimicrob Chemother; 2009 Jul; 64(1):73-8. PubMed ID: 19398458
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Yang JC; Lee PI; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1369-75. PubMed ID: 20658256
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Lao CK; Tseng MC; Chiu CH; Chen NY; Chen CH; Chung WH; Liu TP; Lu JJ; Lai HC; Yang LY; Lee CH; Wu TS
J Formos Med Assoc; 2022 Oct; 121(10):2109-2122. PubMed ID: 35811270
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing.
Hansen G; Swanzy S; Gupta R; Cookson B; Limaye AP
Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):115-20. PubMed ID: 17992548
[TBL] [Abstract][Full Text] [Related]
6.
Pham J; Benefield RJ; Baker N; Lindblom S; Canfield N; Gomez CA; Fisher M
Antimicrob Agents Chemother; 2024 May; 68(5):e0168623. PubMed ID: 38534103
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp.
Yazawa K; Mikami Y; Ohashi S; Miyaji M; Ichihara Y; Nishimura C
J Antimicrob Chemother; 1992 Feb; 29(2):169-72. PubMed ID: 1506332
[TBL] [Abstract][Full Text] [Related]
9. Nocardiosis at the turn of the century.
Minero MV; Marín M; Cercenado E; Rabadán PM; Bouza E; Muñoz P
Medicine (Baltimore); 2009 Jul; 88(4):250-261. PubMed ID: 19593231
[TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiological characteristics of infections caused by various Nocardia species in Taiwan: a multicenter study from 1998 to 2010.
Liu WL; Lai CC; Ko WC; Chen YH; Tang HJ; Huang YL; Huang YT; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1341-7. PubMed ID: 21461846
[TBL] [Abstract][Full Text] [Related]
11. [
Li B; Guo Q; Chu HQ
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Nov; 44(11):947-952. PubMed ID: 34758520
[No Abstract] [Full Text] [Related]
12. [Antimicrobial susceptibilities of clinical Nocardia isolates identified by 16S rRNA gene sequence analysis].
Uner MC; Hasçelik G; Müştak HK
Mikrobiyol Bul; 2016 Jan; 50(1):11-20. PubMed ID: 27058325
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.
Cercenado E; Marín M; Sánchez-Martínez M; Cuevas O; Martínez-Alarcón J; Bouza E
Antimicrob Agents Chemother; 2007 Mar; 51(3):1102-4. PubMed ID: 17194827
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility profile of
Sharma S; Banerjee T; Yadav G; Kumar A
Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
[TBL] [Abstract][Full Text] [Related]
15.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923878
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis.
Hashemi-Shahraki A; Heidarieh P; Bostanabad SZ; Hashemzadeh M; Feizabadi MM; Schraufnagel D; Mirsaeidi M
Sci Rep; 2015 Dec; 5():17862. PubMed ID: 26638771
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
Brown-Elliott BA; Killingley J; Vasireddy S; Bridge L; Wallace RJ
J Clin Microbiol; 2016 Jun; 54(6):1586-1592. PubMed ID: 27053677
[TBL] [Abstract][Full Text] [Related]
18. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
Wei M; Xu X; Yang J; Wang P; Liu Y; Wang S; Yang C; Gu L
BMC Microbiol; 2021 Dec; 21(1):342. PubMed ID: 34903163
[TBL] [Abstract][Full Text] [Related]
19. Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.
Conville PS; Brown-Elliott BA; Wallace RJ; Witebsky FG; Koziol D; Hall GS; Killian SB; Knapp CC; Warshauer D; Van T; Wengenack NL; Deml S; Woods GL
J Clin Microbiol; 2012 Apr; 50(4):1270-80. PubMed ID: 22219309
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
